American Thoracic symposium, Dallas (ATS)

Vicore’s ATTRACT study shows promise for novel drug C21 against COVID-19 in hospitalised patients

Patient insights to shape development of a dCBT for IPF patients

Interview with Ella Radvogin, Clinical Psychologist at Alex Therapeutics

Untangling the dualistic components of the RAS in PF the Yin and Yang

Idiopathic Pulmonary Fibrosis (IPF) – weathering the pandemic